Diabetes Technology Archive

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.

First CGM System With Implantable Glucose Sensor Approved

First CGM System With Implantable Glucose Sensor Approved

The sensor is coated with a fluorescent chemical which produces a small amount of light when exposed to blood glucose.

FDA Clears Omnipod DASH System for Diabetes Management

FDA Clears Omnipod DASH System for Diabetes Management

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod.

Asymptomatic Hypoglycemia Risk With Frequent Hypoglycemia in T1D

Asymptomatic Hypoglycemia Risk With Frequent Hypoglycemia in T1D

Investigators recorded hypoglycemic symptoms and monitored blood sugar levels by continuous glucose monitoring for 6 days.

Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring

Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring

Investigators seek to determine he effects of continuous glucose monitoring on daytime and nocturnal hypoglycemia in patients with type 1 diabetes.

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

For adults with type 1 diabetes with suboptimal control despite using multiple insulin injections, continuous glucose monitoring seems cost-effective, with improved glucose control.

Pharmacists Can Help With Diabetes Management via Telemedicine

Pharmacists Can Help With Diabetes Management via Telemedicine

Telemedicine could provide real-time feedback loop and allow pharmacists to help patients self-manage.

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

The FDA Digital Health Software Precertification Program represents a feasible solution to regulate software classified as a medical device.

FDA Approves Unique Device for Diabetic Retinopathy Screening

FDA Approves Unique Device for Diabetic Retinopathy Screening

This is the first device authorized for marketing that provides a screening decision without the need for clinician interpretation.

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

Users also have access to the Company's Sugar.IQ app, which uses IBM's Watson Health platform, to identify glucose patterns based on factors that may affect them (ie, food intake, insulin dosages, daily routines).

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

Researchers assessed the safety and accuracy of an implantable continuous glucose measurement in adults diagnosed with type 1 and type 2 diabetes.

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

The FDA reviewed data for the device through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices that are not substantially equivalent to an already legally marketed device.

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

For pregnant women with type 1 diabetes, a closed-loop system is associated with comparable glucose control and significantly less hypoglycemia than sensor-augmented pump therapy.

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

Research findings indicate improved glycemic outcomes in children with T1D using the MiniMed 670G system, similar to those observed for adolescents and adults.

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend to youth with T2D.

Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System

Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System

Study suggests that single-hormone artificial pancreas systems may be sufficient for overnight control even in a high-risk group of hypoglycemia-unaware participants with documented nocturnal hypoglycemia.

Novel Deep Learning System May Help Identify Diabetic Retinopathy

Novel Deep Learning System May Help Identify Diabetic Retinopathy

A novel deep learning system has high sensitivity and specificity for identifying diabetic retinopathy.

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

In this phase 3 study, statistically and clinically meaningful improvements in HbA1c, body weight, and the proportion of patients achieving goal HbA1c <7% (53mmol/mol) were demonstrated with 2 doses of ITCA 650 vs placebo.

New Continuous Glucose Monitoring System Now Available for Medicare Patients

New Continuous Glucose Monitoring System Now Available for Medicare Patients

A new continuous glucose monitoring system that allows patients to capture real-time glucose readings without use calibration or routine fingersticks is now available.

New Insulin Pen With Smartphone App, Bolus Advisor Available

New Insulin Pen With Smartphone App, Bolus Advisor Available

The system is able to calculate and recommend optimal insulin dose, track the timing of doses, monitor insulin temperature, remind users to take insulin, and create reports for the healthcare provider.

New Consensus Recommendations on Use of Continuous Glucose Monitoring

New Consensus Recommendations on Use of Continuous Glucose Monitoring

The Advanced Technologies & Treatments for Diabetes (ATTD) Congress summarize consensus recommendations on the current understanding of how CGM results can affect outcomes.

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

Patients from 3 sites participated in a trial examining the noninferiority of telemedicine vs standard outpatient care for diabetic foot ulcer follow-up treatment.

Real-Time Continuous Glucose Monitoring Beneficial But Challenges Remain

Real-Time Continuous Glucose Monitoring Beneficial But Challenges Remain

Although sharing of real-time continuous glucose monitoring data can create tension between patients with type 1 diabetes and family members, it can also facilitate greater empowerment and perceptions of safety among both patients and their caregivers.

Effect of SGLT2 Inhibitors on Early Metabolic Decompensation in T1D

Effect of SGLT2 Inhibitors on Early Metabolic Decompensation in T1D

Patients with T1D are not susceptible to accelerated lipolysis and ketogenesis, despite the reduction in overnight basal insulin doses during SGLT2i treatment.

Predictive Glucose Management Systems May Reduce Hypoglycemia in Pediatric Diabetes

Predictive Glucose Management Systems May Reduce Hypoglycemia in Pediatric Diabetes

A study examined the efficacy and safety of predictive low-glucose management systems for the prevention of hypoglycemia in adolescents with type 1 diabetes.

Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D

Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D

Participants reported improvements in many psychosocial variables associated with using an automated bihormonal bionic pancreas system relative to self-management of diabetes using their own insulin pump.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

Recommendations for utilizing trend arrow data in a mobile continuous glucose monitoring system were recently issued for pediatric patients with type 1 diabetes.

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

Patients with prior experience using a continuous glucose monitoring system may benefit from the MiniMed 670G HCL system therapy.

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

A remotely connected diabetes management system increased patent satisfaction and improved glycemic control in patients with insulin-treated diabetes.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Interpreting trend arrow data from continuous glucose monitoring may provide additional data to improve glycemic control in adults with diabetes mellitus.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Machines were used to examine the glycemic impact of various meals to determine a glucose forecast.

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

Continuous Glucose Monitoring Improves HbA1c in T1D

Continuous Glucose Monitoring Improves HbA1c in T1D

Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

The system allows patients and their caregivers to access glucose measurements through their pump or through a mobile app.

Contour Next One Glucose Monitoring System Approved by FDA

Contour Next One Glucose Monitoring System Approved by FDA

The Contour®Next One Blood Glucose Management System will be available in early 2017.

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

An implantable continuous glucose monitor appears to be a safe and effective alternative to a transcutaneous monitor in diabetes.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.

Artificial Pancreas Moving Steadily Toward Commercial Approval

Artificial Pancreas Moving Steadily Toward Commercial Approval

The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

The system was feasible, safe, and effective for managing hyperglycemia in this patient population.

Artificial Pancreas Protocol Considered Safe, Feasible for Young Children With Type 1 Diabetes

Artificial Pancreas Protocol Considered Safe, Feasible for Young Children With Type 1 Diabetes

Artificial pancreas was linked to 3-fold reduction of time-in-hypoglycemia for 5- to 9-year-olds.

Digital Assistant to Artificial Pancreas Improved Glucose Control in Type 1 Diabetes

Digital Assistant to Artificial Pancreas Improved Glucose Control in Type 1 Diabetes

Overnight-only and 24/7 closed-loop control reduced hypoglycemia and increased time in range.

Sweat-Sensing Patch Can Monitor Glucose Levels, Deliver Diabetes Medication

Sweat-Sensing Patch Can Monitor Glucose Levels, Deliver Diabetes Medication

Experimental technology senses blood glucose and delivers medicine with microneedles.

Insulin Pump Therapy Had Durable Effect in Type 2 Diabetes

Insulin Pump Therapy Had Durable Effect in Type 2 Diabetes

Insulin pump therapy is more effective than multiple daily injections for glycemic control in patients with type 2 diabetes.

Long-Term Insulin Pump Therapy Decreases Mortality in Type 1 Diabetes

Long-Term Insulin Pump Therapy Decreases Mortality in Type 1 Diabetes

Long-term use of insulin pump reduces fatal coronary heart disease, cardiovascular disease and all-cause mortality.

Imperium Instant Patch Insulin Pump Launched

Imperium Instant Patch Insulin Pump Launched

Unilife Corporation announced the launch of the Imperium, the first instant patch pump for insulin with Bluetooth connectivity for patients with diabetes.

Blood Glucose Meter Accuracy Called Into Question

Blood Glucose Meter Accuracy Called Into Question

The paper raises questions regarding safety for measuring blood glucose, and when blood glucose meters are used in trials.

'Smart' Insulin Patch Shows Promise for Diabetes

'Smart' Insulin Patch Shows Promise for Diabetes

The novel technology could be a game-changer for patients with diabetes.

A Call for Improved Surveillance of Insulin Pump Therapy

A Call for Improved Surveillance of Insulin Pump Therapy

Experts are now calling for a more standardized and transparent approach to identifying and reporting adverse events with insulin pump therapy.

Insulin Pump Safety Addressed in Joint Statement

Insulin Pump Safety Addressed in Joint Statement

A statement from the EASD and the ADA indicates that modern insulin pump technologies could be further improved by adopting a more rigorous, standardized and transparent approach to safety.

FDA Clears t:flex Insulin Pump for Marketing

FDA Clears t:flex Insulin Pump for Marketing

The FDA has cleared the t:flex Insulin Pump, which has the largest capacity available in the U.S., for marketing.

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring system for patients with diabetes.

Artificial Pancreas Effective in Unsupervised, At-Home Setting

Artificial Pancreas Effective in Unsupervised, At-Home Setting

Type 1 diabetes patients experienced improved glucose control and less hypoglycemia with use of an artificial pancreas vs. sensor-augmented pump therapy.

Roche Launches First Glucose Meter With Insulin Calculator

Roche Launches First Glucose Meter With Insulin Calculator

Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator.

The Artificial Pancreas: Revolutionizing Type 1 Diabetes Care

The Artificial Pancreas: Revolutionizing Type 1 Diabetes Care

Patients with type 1 diabetes may improve glucose control while reducing the frequency of hypoglycemic episodes with the arrival of the artificial pancreas.

Sign Up for Free e-Newsletters



CME Focus